Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels
Authors:
- Andrea NataliANAndrea Natali
- Elena ToschiETElena Toschi
- Stephanie BaldewegSBStephanie Baldeweg
- Arturo CasolaroACArturo Casolaro
- Simona BaldiSBSimona Baldi
- Anna Maria SironiASAnna Maria Sironi
- John S. YudkinJYJohn S. Yudkin
- Ele FerranniniEFEle Ferrannini
Open Access
- 3 February 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (5) , 464-471
Abstract
Aims In conditions such as type 2 diabetes, hypertension, and smoking, in which haematocrit (Hct) tends to be higher, endothelial function is impaired. In vitro, haemoglobin neutralizes nitric oxide very effectively. Whether red blood cells participate in the regulation of endothelial function in vivo has not been established. Methods and results Clinical and haematological parameters and forearm blood flow responses to acetylcholine (ACh) and sodium nitroprusside (SNP) were measured in 84 type 2 diabetic patients and 19 control subjects. Diabetics showed blunted dose–response curves to both SNP and ACh. In diabetics, across quartiles of Hct, ACh blood flow responses were progressively lower (881±96, 652±81, 513±54, 307±46%, PP=0.06) despite similar age, body mass index, glycated haemoglobin (HbA1c), blood pressure, serum total and HDL-cholesterol levels, indices of insulin sensitivity, and markers of inflammation. After normalizing the ACh response for the SNP response (ACh/SNP ratio), a progressive reduction across Hct quartiles (1.54±0.23, 1.22±0.15, 0.93±0.09, 0.66±0.09, Pr=−0.46 and r=−0.66, respectively, PConclusion Both in diabetics and non-diabetics, haematocrit is inversely related to small vessel endothelium-dependent dilatation. Thus, in addition to blood rheology, a direct negative effect on nitric oxide availability might explain the link between high Hct and cardiovascular disease.Keywords
This publication has 21 references indexed in Scilit:
- Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditionsProceedings of the National Academy of Sciences, 2002
- Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery DiseaseCirculation, 2001
- New aspects of the insulin resistance syndrome: impact on haematological parametersDiabetologia, 2001
- Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxidedeliveryJournal of Clinical Investigation, 2001
- Blood viscosity and th erisk of death from coronary heart diseaseEuropean Heart Journal, 2000
- Blood Rheology, Cardiovascular Risk Factors, and Cardiovascular Disease: The West of Scotland Coronary Prevention StudyThrombosis and Haemostasis, 2000
- Hematocrit and Risk of NIDDMDiabetes, 1996
- Hypertension in mice lacking the gene for endothelial nitric oxide synthaseNature, 1995
- Hematocrit, blood pressure, and hypertension. The Gubbio Population Study.Hypertension, 1992
- Hematocrit and the risk of coronary heart disease: The Honolulu Heart ProgramAmerican Heart Journal, 1983